Immunity gene therapeutic technologies predicted market dominance in 10 years.
Published: 2004-05-19 06:57:00
Updated: 2004-05-19 06:57:00
A bio technology expert predicted that the immunity gene therapy would be recognized as a leading therapeutic technology in coming years, and so important that its provisional ground and infrastructure should be built up as early as possible.
Director Sohn Jong-moon of Genexin Co. reported in ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
